Temasek Holdings (Pte.) Ltd. is looking to sell its 20% stake in Zuellig Pharma Asia Pacific, Bloomberg News reported, citing people familiar with the matter.
The Singapore state investment firm is in discussions with advisers and may seek about $1 billion for its holding in the Asian drug distributor, the people said.
The sale could draw interest from strategic buyers including Mitsui & Co. Ltd. and private equity firms.
The discussions are at an early stage and may not lead to a transaction.
